Bloomage BioTechnology is based in Jinan, China. It has raised $348M in total funding. Latest round: IPO. Backed by Shandong New Kinetic Fund Management.
Bloomage BioTechnology funding overview
Bloomage BioTechnology is based in Jinan, China. Bloomage BioTechnology has raised $348M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in November 2019. The round record for Bloomage BioTechnology runs through 2019; nothing later has been disclosed. Investors on record include Shandong New Kinetic Fund Management.
Bloomage BioTechnology at a glance
Total raised
$348M
Latest round
IPO
Latest round date
November 2019
Headquarters
Jinan, China
Notable investors
Shandong New Kinetic Fund Management
Frequently asked about Bloomage BioTechnology funding
How much has Bloomage BioTechnology raised?
Bloomage BioTechnology has raised $348M in total disclosed funding across the rounds on record.
Who has invested in Bloomage BioTechnology?
Shandong New Kinetic Fund Management are named among the investors backing Bloomage BioTechnology.
What was the latest Bloomage BioTechnology funding round?
The most recent disclosed round is an IPO, announced in November 2019.
Where is Bloomage BioTechnology based?
Bloomage BioTechnology is based in Jinan, China.
When did Bloomage BioTechnology last raise?
The last disclosed Bloomage BioTechnology round closed in November 2019 at IPO.
We update the Bloomage BioTechnology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Jinan and their backers are listed below.
